Biopharmaceuticals Pipeline Glycotope’s mature pipeline of first-in-class and best-in-class biopharmaceuticals Find out more
Biopharmaceuticals Services Glycotope Biotechnology’s unique combination of development and production expertise Find out more

Using world-leading glycobiology expertise to improve outcomes for patients

About
An introduction to our company, experienced leadership and Board
Technology
Learn how we are leveraging our proprietary technologies to drive innovation
PankoMab-GEX®
Our first-in-class antibody against a tumor-specific carbohydrate-protein epitope
Careers
Join us
News
19. Sep
2017
Glycotope outlicenses GlycoExpress® Cell Line to Airway Therapeutics

Berlin, Germany, 19 September 2017 – Glycotope GmbH [Glycotope], a clinical-stage immuno-oncology company built […]

29. Apr
2016
Glycotope Appoints Dr. Alfredo Zurlo as Chief Medical Officer

Glycotope GmbH, a clinical-stage immuno-oncology company built on world-leading glyco-biology expertise, today announces the […]

See All News
Events
06-08 Nov
2017
BIO Europe
08-12 Jan
2018
PepTalk: The Protein Science Week
See All Events